Bertoli, S., Bérard, E., Peterlin, P., Guieze, R., Desbrosses, Y., Hicheri, Y., Benbrahim, O., Carre, M., Orvain, C., Banos, A., Bernard, M., Gyan, E., Saad, A., Chebrek, S., Guepin, G. R., Dorvaux, V., Sanhes, L., Gallego-Hernanz, M. P., Exbrayat, C., Vincent, L., Himberlin, C., Simand, C., Vey, N., Fenoll, C., Mineur, A., Huynh, A., Vergez, F., Luquet, I., Largeaud, L., Delabesse, E., Pigneux, A., Récher, C. and Leukemia Organization FILO, F. I. (2020) “Dexamethasone added to induction and post-remission therapy in older patients with newly diagnosed acute myeloid leukemia: a multicenter, phase II trial (DEXAML-02)”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.286807.